Last update:
Coronavirus (COVID-19)
Biotechnology
Artificial receptors made from coronavirus DNA open up new avenues for research
A team of microbiologists and virologists at Wuhan University, working with colleagues from the Chinese Academy of Sciences, the University of Washington and Humabs BioMed SA, has found that it is possible to use coronavirus ...
Nov 6, 2024
0
46
COVID-19 outbreak
Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.
Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.
More information: WHO, CDC, global cases.
Follow us on Google News for the latest updates on the coronavirus.
Novel nano-vaccine administered as nasal spray found to be effective against all major COVID-19 variants
Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored at room temperature and administered as a nasal spray
Nov 21, 2024
0
24
Seemingly 'broken' genes in coronaviruses may be essential for viral survival
Viruses are lean, mean, infection machines. Their genomes are tiny, limited to a handful of absolutely essential genes, and they shed extra genomic deadweight extremely fast... usually.
Nov 19, 2024
0
6
Political polarization poses health risks, new analysis concludes
News coverage of the 2024 election season has often centered on how partisan division has affected our politics. But a new analysis shows that political polarization also poses significant health risks—by obstructing the ...
Oct 25, 2024
0
36
Vaccine against the MERS coronavirus tested as safe and effective in phase Ib clinical trial
The MERS coronavirus—MERS stands for "Middle East respiratory syndrome"—causes severe respiratory diseases with a high mortality rate. To date, there is neither a vaccine nor a specific treatment. The safety, immunogenicity ...
Oct 21, 2024
0
41
New mouse models offer valuable window into COVID-19 infection
Scientists at La Jolla Institute for Immunology (LJI) have developed six lines of humanized mice that can serve as valuable models for studying human cases of COVID-19.
Oct 1, 2024
0
31
Study confirms effectiveness of the new omicron booster
The autumn wave of coronavirus is sweeping across Germany. Those affected mainly suffer from coughs, colds, sore throats and fever, but also from headaches, aching limbs, general weakness and shortness of breath. Because ...
Sep 26, 2024
0
62
Younger patients more affected by neurologic manifestations of long COVID
Younger and middle-aged patients seem to be disproportionately affected by neurologic manifestations of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (Neuro-PASC), according to a study published ...
Nov 22, 2024
0
4
Study reveals COVID-19 vaccine safety in patients with atrial fibrillation/flutter
Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the current endemic status of COVID-19, ...
Nov 14, 2024
0
21
Q&A: Looking at ancient Roman plagues through an environmental lens
A pit of human bones, potential evidence of a catastrophic epidemic that struck Constantinople in 541 A.D. Sulfur deposits trapped in polar ice, showing traces of a series of massive volcanic eruptions. For Brandon McDonald, ...
Nov 7, 2024
0
2
Discovery of rapid COVID-19 replication mechanism could expand treatment options
Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming to prepare for future infectious diseases. A research team has newly identified the mechanism behind ...
Nov 6, 2024
0
0
Some COVID test expiration dates have been extended, FDA says
Don't automatically throw out that old COVID-19 at-home test you just came across in your medicine cabinet.
Nov 1, 2024
0
0
Delayed antibody treatment may improve efficacy of mRNA vaccines
Investigators led by Pablo Penaloza-MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination enhances immune responses and ...
Oct 28, 2024
0
0
Malicious social media bots increased significantly during the COVID-19 pandemic, finds study
The information environment in Finland during the coronavirus pandemic was exceptional and intense in many ways. The spread of disinformation and the number of actors involved reached unprecedented levels.
Oct 25, 2024
0
0
Floor swabbing could help prevent COVID-19 outbreaks in hospitals
COVID-19 is here to stay. As restrictions and human testing have waned, new research is tackling the challenge of how we can monitor, predict, and prevent cases and outbreaks of COVID-19, especially among vulnerable groups ...
Oct 22, 2024
0
14
Survery: Public worry about RSV has faded, unlike flu and COVID-19
More than 100,000 older adults are hospitalized on average yearly in the United States with RSV (respiratory syncytial virus), as are 58,000 or more infants and young children under the age of 5, according to the Centers ...
Oct 15, 2024
0
42
Is COVID-19 infecting wild animals? Researcher test species from bats to seals to find out
Over the course of the COVID-19 pandemic, researchers have found coronavirus infections in pet cats and dogs and in multiple zoo animals, including big cats and gorillas. These infections have even happened when staff were ...
Oct 11, 2024
0
1
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist—a concept once ...
Oct 10, 2024
0
9
Do at-home COVID tests actually expire?
While many respiratory viruses—including COVID-19, RSV and influenza—circulate year-round in California, they are typically more active between October and March, according to the California Department of Public Health.
Oct 9, 2024
0
1
